Novo Nordisk | NVO - Trade Creditors

Stock Price
43.35
Daily Change
-3.83 -8.12%
Monthly
-22.89%
Yearly
-50.26%
Q1 Forecast
56.42

Novo Nordisk reported DKK4.46B in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
ANI Pharmaceuticals USD 69.8M 15.23M Sep/2025
Aurora Cannabis CAD 49.34M 31.94M Sep/2025
Bausch Health Companies USD 616M 11M Sep/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Canopy Growth CAD 18.14M 5.94M Sep/2025
Corcept Therapeutics USD 34.45M 10.92M Sep/2025
Drreddys Laboratories INR 454.04M 854K Dec/2025
Eli Lilly USD 4.26B 186.5M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Merck USD 4.15B 102M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Novo Nordisk DKK 19.76B 4.15B Dec/2025
Novo Nordisk DKK 4.46B 15.12B Jun/2025
Pacira USD 17.69M 12.44M Sep/2025
Perrigo USD 469.7M 19.3M Sep/2025
Prestige Brands USD 42.95M 1.02M Dec/2025
Sanofi EUR 22.93B 927M Dec/2025
Supernus Pharmaceuticals USD 108.61M 100.4M Sep/2025
Zoetis USD 410M 98M Sep/2025